Mitochondrial Regulation of the NLRP3 Inflammasome in Diabetic Kidney Disease: From Mechanisms to Therapeutic Strategies

Read full text
Authors: Xiangyu Chen, Zhenyu Wu, Kaiyan Yu, Juan Zhang, Hongjie Di
Cited by: 1
References: 181

Abstract

Despite current therapies, persistent chronic inflammation remains an important contributor to residual renal risk in diabetic kidney disease (DKD). The NLRP3 inflammasome is a key driver of this inflammatory cascade, with mitochondria serving as a central hub that translates metabolic stress into NLRP3 activation via mitochondrial reactive oxygen species (mtROS) and oxidized mitochondrial DNA (ox-mtDNA). This review delineates the signaling network of the mitochondria-NLRP3 inflammasome axis in DKD and evaluates its potential as a therapeutic target to improve patient outcomes.

Fields of Study & Subjects

Inflammasome and immune disorders Dialysis and Renal Disease Management Acute Kidney Injury Research

Publication details

Journal / source
International Journal of Molecular Sciences
Publisher
MDPI AG
Volume
27
Issue
11
Pages
4819–4819
Publication date
27 May 2026
Language
EN